Long-term Survival after Treatment of Synchronous Isolated Right External Iliac Lymph Node Metastasis from Ascending Colon Cancer: A Case Report.
Colon, Ascending
/ pathology
Lymphatic Metastasis
Lymph Nodes
/ pathology
Humans
Colonic Neoplasms
/ drug therapy
Ilium
Female
Aged
Colectomy
Chemotherapy, Adjuvant
Neoplasm Recurrence, Local
/ diagnosis
Capecitabine
/ therapeutic use
Oxaliplatin
/ therapeutic use
Antineoplastic Agents
/ therapeutic use
Ascending colon cancer
Case report
Isolated distant lymph node metastasis
Surgical resection
Journal
The Kobe journal of medical sciences
ISSN: 1883-0498
Titre abrégé: Kobe J Med Sci
Pays: Japan
ID NLM: 0413531
Informations de publication
Date de publication:
21 Aug 2023
21 Aug 2023
Historique:
medline:
5
9
2023
pubmed:
4
9
2023
entrez:
4
9
2023
Statut:
epublish
Résumé
Synchronous isolated external iliac lymph node metastasis of ascending colon cancer is extremely rare, and its treatment strategy has not been established. In this report, we present a case of long-term survival after surgical resection and adjuvant chemotherapy for ascending colon cancer with synchronous isolated right external iliac lymph node metastasis. A 65-year-old woman with anorexia and anemia was referred to our hospital. Colonoscopy and computed tomography revealed a three-quarter circumferential type 2 tumor from the cecum to the ascending colon, along with regional and right external iliac lymph node swelling. We diagnosed ascending colon cancer with right external iliac artery lymph node metastasis. An open right hemicolectomy with D3 and right external iliac lymph node dissections were performed. Results of histopathological examination showed that both lymph nodes were metastasized from ascending colon cancer. The patient received eight courses of capecitabine and oxaliplatin therapy as adjuvant chemotherapy. At 60 months after surgery, the woman has not had a recurrence. Surgical resection and adjuvant chemotherapy may be an effective treatment strategy for synchronous isolated right external iliac lymph node metastases from ascending colon cancer.
Sections du résumé
BACKGROUND
BACKGROUND
Synchronous isolated external iliac lymph node metastasis of ascending colon cancer is extremely rare, and its treatment strategy has not been established. In this report, we present a case of long-term survival after surgical resection and adjuvant chemotherapy for ascending colon cancer with synchronous isolated right external iliac lymph node metastasis.
CLINICAL CASE
METHODS
A 65-year-old woman with anorexia and anemia was referred to our hospital. Colonoscopy and computed tomography revealed a three-quarter circumferential type 2 tumor from the cecum to the ascending colon, along with regional and right external iliac lymph node swelling. We diagnosed ascending colon cancer with right external iliac artery lymph node metastasis. An open right hemicolectomy with D3 and right external iliac lymph node dissections were performed. Results of histopathological examination showed that both lymph nodes were metastasized from ascending colon cancer. The patient received eight courses of capecitabine and oxaliplatin therapy as adjuvant chemotherapy. At 60 months after surgery, the woman has not had a recurrence.
CONCLUSIONS
CONCLUSIONS
Surgical resection and adjuvant chemotherapy may be an effective treatment strategy for synchronous isolated right external iliac lymph node metastases from ascending colon cancer.
Substances chimiques
Capecitabine
6804DJ8Z9U
Oxaliplatin
04ZR38536J
Antineoplastic Agents
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
E52-E56Références
Lancet Oncol. 2013 Nov;14(12):1208-15
pubmed: 24120480
Ann Surg Oncol. 2014 Apr;21(4):1276-86
pubmed: 24346766
Ann Oncol. 2018 Mar 1;29(3):624-631
pubmed: 29293874
Ann Surg. 2013 Jun;257(6):1059-64
pubmed: 23001087
J Clin Oncol. 2021 Dec 1;39(34):3789-3799
pubmed: 34520230
Surg Case Rep. 2017 Dec;3(1):32
pubmed: 28220469
Lancet Oncol. 2013 Dec;14(13):1278-86
pubmed: 24225157
Eur J Surg Oncol. 2016 Sep;42(9):1337-42
pubmed: 27160353
Surg Today. 2013 Jan;43(1):88-90
pubmed: 23111463
Jpn J Clin Oncol. 2022 Jul 8;52(7):735-741
pubmed: 35393617
J Surg Oncol. 2023 Mar;127(4):645-656
pubmed: 36350234
Int Cancer Conf J. 2020 May 27;9(3):162-167
pubmed: 32582524
Int J Clin Oncol. 2018 Feb;23(1):1-34
pubmed: 28349281
N Engl J Med. 2014 Oct 23;371(17):1609-18
pubmed: 25337750
Jpn J Clin Oncol. 2007 Mar;37(3):230-2
pubmed: 17472973
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593